Abstract
The adenoviruses of humans, of which there are now 41 serotypes, are naked icosahedrons, 70–90 nm in diameter, and contain a genome composed of linear double-stranded DNA. They are associated with a wide spectrum of diseases (Table I) and they have been isolated from virtually all organs, but they are primarily regarded as common pathogens of the respiratory tract and eye. Most individuals become infected early in life with at least several sero types. To a certain extent, the kinds of adenovirus-associated diseases to which people become susceptible change as they grow older; each of these illnesses is caused by a limited number of serotypes. With rare exceptions, adenovirus infections are short-lived and self-limited.
Chapter PDF
Similar content being viewed by others
Keywords
- Acquire Immune Deficiency Syndrome
- Adenovirus Infection
- Adenovirus Type
- Human Adenovirus
- Severe Combine Immunodeficiency Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Boudin, M.-L., and P. Boulanger, Antibody triggered dissociation of adenovirus penton capsomer, Virology 113:781–786 (1981).
Gerna, G., E. Cattaneo, M. Grazia Revello, M. Battaglia, and G. Achilli, Antibody to human adenovirus early antigens during acute adenovirus infections, Infect. Immun. 32:778–787 (1981).
McCormick, D. P., R. P. Wenzel, J. A. Davies, and W. E. Beam, Nasal secretion protein responses in patients with wild-type adenovirus disease, Infect. Immun. 6:282–288 (1972).
Gupta, A. K., and G. S. Sarin, Serum and tear immunoglobulin levels in acute ade novirus conjunctivitis, Br. J. Ophthalmol. 67:195–198 (1983).
Top, F. H., Jr., Control of adenovirus acute respiratory disease in U.S. Army trainees, Yale J. Biol. Med. 48:185–195 (1975).
Top, F. H., R. A. Grossman, P. J. Bartelloni, H. E. Segal, B. A. Dudding, P. K. Russell, and E. L. Buescher, Immunization with live types 7 and 4 adenovirus vaccine. I. Safety, infectivity, antigenicity and potency of adenovirus type 7 vaccine in humans, J. Infect. Dis. 124:148–160 (1971).
Smith, T. J., E. L. Buescher, F. H. Top, W. A. Altemeier, and J. M. McCown, Experi mental respiratory infection with the type 4 adenovirus vaccine in volunteers: Clinical and immunological responses, J. Infect. Dis. 122:239–248 (1970).
Schwartz, A. R., Y. Togo, and R. B. Hornick, Clinical evaluation of live oral types 1,2,5 adenovirus vaccines, Am. Rev. Respir. Dis. 109:233–238 (1974).
Kasel, J. A., R. H. Alford, J. R. Lehrich, P. A. Banks, M. Huber, and V. Knight, Adenovirus soluble antigens for human immunization: A progress report, Am. Rev. Respir. Dis. 94:170–174 (1966).
Jen, K.-F., Y. Tai, Y.-C. Lin, and H.-Y. Wang, The role of adenovirus in the etiology of infantile pneumonia and pneumonia complicating measles, Chinese Med. J. 81:141–146 (1962).
Schonland, M., M. L. Strong, and A. Wesley, Fatal adenovirus pneumonia: Clinical and pathological features, S. Afr. Med. J. 50:1748–1751 (1976).
Lang, W. R., C. W. Howden, J. Laws, and J. F. Burton, Bronchopneumonia with serious sequelae in children with evidence of adenovirus type 21 infection, Br. Med. J. 1:73–79 (1969).
Keller, E. W., R. H. Rubin, P. H. Black, and M. Hirsch, Isolation of adenovirus type 34 from a renal transplant recipient with interstitial pneumonia, Transplantation 23:188– 190 (1977).
Stalder, H., J. C. Hierholzer, and M. Oxmar, New human adenovirus (candidate adenovirus type 35) causing fatal disseminated infection in a renal transplant patient,/. Clin. Microbiol. 6:257–265 (1977).
dejong, P. J., G. Valderrama, I. Spigland, and M. S. Horwitz, Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome, Lancet 1:1293–1296 (1983).
Wigger, H. J. and W. A. Blanc, Fatal hepatitis and necrosis in adenovirus infection with thymic alymphoplasia, N. Engl. J. Med. 275:870–874 (1966).
Dudding, B. A., S. C. Wagner, J. A. Zeller, J. T. Gmelich, E. R. French, and F. H. Top, Fatal pneumonia associated with adenovirus type 7 in three military trainees, N. Engl. J. Med. 286:1289–1292 (1972).
Strieder, D. J., and G. Nash, Weekly clinicopathological exercises. Case 12–1975, N. Engl. J. Med. 292:634–640 (1975).
Varsano, I., T. M. Schonfeld, Y. Matoth, B. Shohat, T. Englander, V. Rotter, and N. Trainin, Severe disseminated adenovirus infection successfully treated with a thymic humoral factor, Acta Paediatr. Scand. 66:329–331 (1977).
Horvath, J., G. Kolesar, J. P. Ugryumov, P. Das, I. Nasz, Z. F. Barinsky, G. Simon, and J. Ongradi, Effect of adenovirus infection on human peripheral lymphocytes, Acta Microbiol. Hung. 30:203–209 (1983).
Huang, S.-W., D. B. Lattos, D. B. Nelson, K. Reeb, and R. Hong, Antibody-associated lymphotoxin in acute infection, J. Clin. Invest. 52:1033–1040 (1973).
Huang, S.-W. and R. Hong, Immunologic deficiences during viral infection. (Letter.), N. Engl. J. Med. 292:1296 (1975).
Berencsi, K., M. Bakay, and I. Beladi, The role of macrophages in adenovirus-induced immunosuppression in mice, Acta Virol. 29:61–65 (1985).
Berencsi, K., M. Bakay, and P. Kovacs, Effect of human adenovirus type 6 on the primary immune response in mice, Acta Virol. 26:340–345 (1982).
Cook, S. L., and A. M. Lewis, Differential NK and macrophage killing of hamster cells infected with nononcogenic or oncogenic adenovirus, Science 224:612–615 (1984).
Gallimore, P. H. and C. Paraskeva, A study to determine the reasons for differences in the tumorigenicity of rat cell lines transformed by adenovirus 2 and adenovirus 12, Cold Spring Harbor Symp. Quant. Biol 44:703–713 (1979).
Mandi, Y., M. Bakay, and I. Beladi, Effect of human adenoviruses on antibody-depen dent cellular cytotoxicity (ADCC) in chickens, Cell. Immunol. 69:395–400 (1982).
Lysov, V. V., O. A. Aksenon, V. I. Rudenko, S. A. Moshkin, T. I. Huyrlova, A. A. Smorodintsev, and A. A. Selivanon, Interference activity and sensitivity to interferon of original and cold strains of adenovirus types 1 and 2, Acta Virol. (Praha) 15:387–392 (1971).
Pusztai, R., K. Berendsi, I. Beladi, and E. Szabo, Relationship between interferon production and transformation of chick cells infected with human adenovirus type 12, in: Interferon and Interferon Inducers (I. Foldes and M. Talas, eds.), pp. 100–108, Research Group of the Hungarian Academy of Sciences, Budapest (1976).
Langford, M. P., A. L. Villarreal, and G. J. Stanton, Antibody and interferon act syn-ergistically to inhibit enterovirus, adenovirus, and herpes simplex virus infection, Infect. Immun. 41:214–218 (1983).
Beladi, I., and R. Pusztai, Interferon-like substance produced in chick fibroblast cells inoculated with human adenovirus, Z. Naturforsch. 226:165–169 (1967).
Ho, M., and K. Kohler, Studies on human adenoviruses as inducers of interferon in chick cells, Arch. Gesamte Virusforsch. 22:69–78 (1967).
Pusztai, R., I. Beladi, M. Bakay, and I. Mucsi, Effect of ultraviolet irradiation and heating on the interferon inducing capacity of human adenoviruses, J. Gen. Virol 4:169–176 (1969).
Toth, M., M. Bakay, B. Torodi, S. Toth, R. Pusztai, and I. Beladi, Different interferon-inducing ability of human adenovirus types in chick embryo cells, Acta Virol. (Praha) 27:337–345 (1983).
Ho, M., Animal viruses and interferon formation, in: Interferon and Interferon Inducers (N. B. Finter ed.), pp. 29–44, North-Holland, Amsterdam (1973).
Romano, A., M. Revel, D. Guarari-Rotman, M. Blumenthal, and R. Stein, Use of human fìbroblast-derived (beta) interferon in the treatment of epidemic adenovirus keratoconjunctivitis, J. Interferon Res. 1:95–100 (1980).
Romano, A., E. Ladizensky, D. Guarari-Rothman, and M. Revel, Clinical effect of human fibroblast-derived (beta) interferon in treatment of adenovirus epidemic keratoconjunctivitis and its complications, Tex. Rep. Biol. Med. 41:559–565 (1981–1982).
Beladi, I., R. Pusztai, I. Mucsi, M. Bakay, and G. Bajszar, Effect of human adenoviruses on the response of chickens to sheep erythrocytes, Infect. Immun. 7:22–28 (1973).
Hamburg, V., O. Scherbakova, and G. Svet-Moldavsky, Suppression of antibody formation against Sendai Virus in SV40 and adenovirus 16 infected hamsters, Experientia 26:532–534 (1970).
Friedman, H., and H. Goldner, Relationship between immunologic maturation and viral oncogenesis in hamsters,/. Natl. Cancer Inst. 44:809–817 (1970).
Strohl, W. A. and R. W. Schlesinger, Quantitative studies of natural and experimental adenovirus infections of human cells, Virology 26:208–220 (1965).
Lambriex, M., and J. van der Veen, Comparison of replication of adenovirus type 2 and type 4 in human lymphocyte cultures, Infect Immun. 14:618–622 (1976).
Faucon, N., and C. Desgranges, Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virus, Infect. Immun. 29:1180–1184 (1980).
Faucon, N., Y. Chardonnet, M. C. Perrinet, and R. Sohier, Superinfection with adenovirus of Burkitt’s lymphoma cell lines, J. Natl. Cancer Inst. 53:305–307 (1974).
Andiman, W. A., R. I. Jacobson, and G. Tucker, Leukocyte-associated viremia with adenovirus type 2 in an infant with lower-respiratory tract disease, N. Engl. J. Med. 297:100–101 (1977).
Andiman, W. A., and G. Miller, Persistent infection with adenovirus types 5 and 6 in lymphoid cells from humans and woolly monkeys, J. Infect. Dis. 145:83–88 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Andiman, W.A., Robert, M.F. (1989). Adenoviruses. In: Specter, S., Bendinelli, M., Friedman, H. (eds) Virus-Induced Immunosuppression. Infectious agents and pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5583-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5583-0_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5585-4
Online ISBN: 978-1-4684-5583-0
eBook Packages: Springer Book Archive